Authored by: Liu Cheng , Audrey Li , Jin Xiaotian , Zhu Qunfei , Xu Shiwei , Ye Hongtao , Zhang Yutong , Zhang Jingyu , Wang Zhiyao and Jiang Hanxue
In 2024, there have been a number of important developments in China’s competition law.
The State Administration for Market Regulation (“SAMR”) issued new antitrust guidelines specifically for the sectors of standard essential patents (“SEPs”) and pharmaceuticals, and its enforcement focused on sectors concerning people’s livelihoods, such as public utilities and pharmaceuticals, as well as intellectual property and high technology.